At a glance
- Originator ASTA Medica [CEASED]
- Class Analgesics; Antipyretics
- Mechanism of Action Thromboxane B2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 02 Dec 1997 Discontinued-Preclinical for Pain in Germany (PO)
- 14 Aug 1995 No-Development-Reported for Pain in Germany (PO)